NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Thalassemia Major


Research from D.A. Stakos et al has provided new information about thalassemia



NewsRx
Thalassemia Major Library
Library Home

This article was published in Biotech Business Week, which you can subscribe to online.

NewsRx
NewsRx
2009 JUL 6 - (NewsRx.com) -- "Cardiovascular complications are common in beta-thalassemia major (beta-TM), mainly attributed to increased cardiac iron depositions. Early cardiovascular involvement in patients without cardiac symptoms and without cardiac iron overload has not been adequately investigated," researchers in Greece report.

"Twenty six patients (11 males) with beta-TM, on chelation therapy, age 23 +/- 4 years without cardiac iron overload (measured by magnetic resonance imaging), and 30 age and gender matched healthy controls were included in the study. Carotid-femoral and carotid radial pulse wave velocity (PWVc-f and PWVc-r) and augmentation index (AI) were measured by SphygmoCor device; carotid intima-media thickness; left ventricular (LV) dimensions and function; left atrial (LA) volume and function were assessed by echocardiography. Patients with beta-TM had higher PWVc-f (8.4 +/- 1.4 vs 7.2 +/- 1.1 m/s, p=0.002) and augmentation index (21.7 +/- 10.9 vs 14.7 +/- 9.7%, p=0.04) indicating decreased aortic elastic properties; greater LV mass index (72.0 +/- 13.3 vs 63.8 +/- 11.5 g/m(2), p=0.04) and greater LA volumes. Multivariate logistic regression analysis revealed that higher PWVc-f was independently associated with higher LV mass [OR 1.74 95% CI (1.09-2.88), p=0.026]; and greater LA dimensions [OR 1.68 95% CI (1.04-2.72), p=0.035]. In the absence of cardiac iron overload, asymptomatic patients with beta-TM demonstrated aortic stiffening associated with increased LV mass and LA enlargement," wrote D.A. Stakos and colleagues.

The researchers concluded: "These alterations may represent signs of early cardiovascular involvement."

Stakos and colleagues published their study in International Journal of Cardiology (Cardiovascular involvement in patients with beta-thalassemia major without cardiac iron overload. International Journal of Cardiology, 2009;134(2):207-211).

For additional information, contact D.A. Stakos, University of Hospital Alexandroupolis, GR-68100 Dragana, Alexandroupolis, Greece.

Publisher contact information for the International Journal of Cardiology is: Elsevier Ireland Ltd., Elsevier House, Brookvale Plaza, East Park Shannon, Co. Clare, Ireland.

Keywords: Greece, Angiology, Beta-Thalassemia, Cardio Device, Cardiography, Cardiology, Cardiovascular, Echocardiography, Gender Health, Gender Medicine, Hematology, Iron Overload, Magnetic Resonance, Medical Device, Thalassemia, Therapy, Treatment, Women's Health.

This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login